Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Leland E Hull

Showing results (11-20 of 22) with videos related to

Pageof 3
Sort By:
Clinical Breast Cancer|January 8, 2018
Clinical Impact of 21-Gene Recurrence Score Test Within the Veterans Health Administration: Utilization and Receipt of Guideline-Concordant CareLeland E Hull, Julie A Lynch, Brygida B Berse, et al.
Journal of General Internal Medicine|January 6, 2026
Evaluating the Acceptability of Virtual Preventive Genetic Counseling Supporting Adult Primary Care PracticesLeland E Hull, Suzanne Brodney, Susan Regan, et al.
Medrxiv : the Preprint Server for Health Sciences|March 3, 2023
Integrative polygenic risk score improves the prediction accuracy of complex traits and diseasesBuu Truong, Leland E Hull, Yunfeng Ruan, et al.
Cell Genomics|March 20, 2024
Integrative polygenic risk score improves the prediction accuracy of complex traits and diseasesBuu Truong, Leland E Hull, Yunfeng Ruan, et al.
Genetics in Medicine Open|December 13, 2024
A pooled electronic consultation program to improve access to genetics specialistsEmma K Folkerts, Renée C Pelletier, Daniel C Chung, et al.
Medrxiv : the Preprint Server for Health Sciences|February 17, 2023
A Pooled Electronic Consultation Program to Improve Access to Genetics SpecialistsEmma K Folkerts, Renée C Pelletier, Daniel C Chung, et al.
Circulation|March 13, 2025
Direct-to-Consumer Genetic Testing for Cardiovascular Disease: A Scientific Statement From the American Heart AssociationLeland E Hull, Aaron W Aday, Quan M Bui, et al.
JAMA Network Open|June 8, 2019
Projected Prevalence of Actionable Pharmacogenetic Variants and Level A Drugs Prescribed Among US Veterans Health Administration Pharmacy UsersCatherine Chanfreau-Coffinier, Leland E Hull, Julie A Lynch, et al.
The Journal of Molecular Diagnostics : JMD|September 27, 2020
Identifying End Users' Preferences about Structuring Pharmacogenetic Test Orders in an Electronic Health Record SystemLeland E Hull, Jason L Vassy, Annjanette Stone, et al.
JACC. Advances|September 23, 2022
Clinical Implementation of Combined Monogenic and Polygenic Risk Disclosure for Coronary Artery DiseaseDimitri J Maamari, Deanna G Brockman, Krishna Aragam, et al.
Pageof 3

Showing results (11-20 of 22) with videos related to

Sort By:
Pageof 3
Clinical Breast Cancer|January 8, 2018
Clinical Impact of 21-Gene Recurrence Score Test Within the Veterans Health Administration: Utilization and Receipt of Guideline-Concordant CareLeland E Hull, Julie A Lynch, Brygida B Berse, et al.
Journal of General Internal Medicine|January 6, 2026
Evaluating the Acceptability of Virtual Preventive Genetic Counseling Supporting Adult Primary Care PracticesLeland E Hull, Suzanne Brodney, Susan Regan, et al.
Medrxiv : the Preprint Server for Health Sciences|March 3, 2023
Integrative polygenic risk score improves the prediction accuracy of complex traits and diseasesBuu Truong, Leland E Hull, Yunfeng Ruan, et al.
Cell Genomics|March 20, 2024
Integrative polygenic risk score improves the prediction accuracy of complex traits and diseasesBuu Truong, Leland E Hull, Yunfeng Ruan, et al.
Genetics in Medicine Open|December 13, 2024
A pooled electronic consultation program to improve access to genetics specialistsEmma K Folkerts, Renée C Pelletier, Daniel C Chung, et al.
Medrxiv : the Preprint Server for Health Sciences|February 17, 2023
A Pooled Electronic Consultation Program to Improve Access to Genetics SpecialistsEmma K Folkerts, Renée C Pelletier, Daniel C Chung, et al.
Circulation|March 13, 2025
Direct-to-Consumer Genetic Testing for Cardiovascular Disease: A Scientific Statement From the American Heart AssociationLeland E Hull, Aaron W Aday, Quan M Bui, et al.
JAMA Network Open|June 8, 2019
Projected Prevalence of Actionable Pharmacogenetic Variants and Level A Drugs Prescribed Among US Veterans Health Administration Pharmacy UsersCatherine Chanfreau-Coffinier, Leland E Hull, Julie A Lynch, et al.
The Journal of Molecular Diagnostics : JMD|September 27, 2020
Identifying End Users' Preferences about Structuring Pharmacogenetic Test Orders in an Electronic Health Record SystemLeland E Hull, Jason L Vassy, Annjanette Stone, et al.
JACC. Advances|September 23, 2022
Clinical Implementation of Combined Monogenic and Polygenic Risk Disclosure for Coronary Artery DiseaseDimitri J Maamari, Deanna G Brockman, Krishna Aragam, et al.
Pageof 3